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In vitro and in vivo interleukin-8 production in human renal cortical
epithalia. The signals resulting in leukocytes infiltrating the tubuloin-
terstitial compartment during renal inflammatory disease are not well
understood. A recently described cytokine, interleukin-8 (IL-8), has
been demonstrated to be chemotactic for lymphocytes and neutrophils
at picomolar and nanomolar concentrations, respectively. Cytokeratin
positive, renal cortical epithelial cells (RCEC) with tubular attributes
were cultured from kidney tissue from six human subjects. We report
that these human renal cortical epithelial cells in primary cell culture
respond to either IL-113, TNF or LPS in both a time- and dose-
dependent manner by expressing IL-8 mRNA and secreting antigenic
IL-8 peptide. In addition, RCEC were found to be strongly positive for
cell-associated antigenic IL-8 peptide by immunostaining after 24 hour
incubation with IL-l/3, TNF and LPS. To ascertain whether IL-8 was
present in renal disease associated with infiltrating leukocytes, we
performed immunohistochemistry on renal biopsy specimens from
patients with acute allograft rejection. Both proximal and distal tubular
epithelial cells were found to be strongly positive for cell-associated
antigenic IL-8. These findings suggest that the human renal tubule
epitheial cell may actively participate in acute inflammatory processes
in the kidney, including allograft rejection, by effecting and directing
leukocyte chemotaxis via the production of IL-8.
Renal interstitial inflammation is a principal cause of both
native and allograft kidney failure [1, 21. A number of inflam-
matory kidney diseases, including transplant rejection, vascu-
litis, glomerulonephritis and pyelonephritis, are associated with
an interstitial nephritis. The predominant histopathology asso-
ciated with this lesion is the presence of leukocytes of both
mononuclear and polymorphonuclear morphology in the renal
interstitium. The mechanism(s) by which cells are attracted into
the tubulointerstitial compartment remains to be fully eluci-
dated. Interleukin-8 (IL-8) is a recently described chemotactic
cytokine [3] with the potential to contribute in directing immune
cell traffic into the renal interstitium.
IL-8, also known as neutrophil chemotactic factor (NCF) and
neutrophil activating peptide-l (NAP-l), was originally de-
scribed as a secreted product from LPS-stimulated human
peripheral blood monocytes that had neutrophil chemotactic
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and activating activity [3]. This cytokine is a potent, highly
stable, soluble chemotactic cytokine at nM and p concentra-
tions for neutrophils and lymphocytes, respectively [4]. It has
also been shown to mediate neutrophil activation at nat to m
concentrations [5]. IL-8 is resistant to many proteases, and its
secretion requires de novo synthesis [5]. Thus, unlike short-
lived chemotactic factors such as complement fragments or
arachadonic acid products, IL-8, with prolonged stability, has
the potential for longer duration of action at sites of tissue
inflammation. Although initially described as a monocyte prod-
uct [3], it has recently been shown that IL-8 is expressed in and
secreted by non-immune types of human cells. These include
primary dermal fibroblasts [6], umbilical vein endothelial cells
[7] and the following cell lines of epithelial origin: pulmonary
A549 [8] and hepatocyte Hep-G2, SK-Hep and Hep-3B [9].
In this manuscript we demonstrate the capability of human
renal cortical epithelial cells isolated from primary culture to
both express IL-8 mRNA and secrete IL-8 antigen in response
to TNF, IL-1f3 and LPS. We also provide in vivo data that show
that renal tubular epithelial cells produce IL-8 during transplant
rejection. These data imply that renal cortical epithelial cells
themselves can act as non-immune effector cells in renal
inflammation by producing IL-8.
Methods
Cell culture
Human renal cortex-derived epithelial cells were isolated
using previously reported techniques [10]. Briefly, 2 cm3 of
human renal cortex was obtained from the non-involved pole at
the time of elective nephrectomy for hypernephroma or transi-
tional cell carcinoma, and placed in ice cold, sterile normal
saline. The capsule was removed, the medulla dissected away,
and the cortex diced in cold sterile saline to form a slurry of
approximately Ito 2 mm pieces. The slurry was transferred into
a sterile flask containing 150 to 200 ml 0.25% trypsin (porcine)
in phosphate buffered saline and gently stirred for 30 minutes at
37°C. The contents of the flask were then filtered through one
layer of sterile gauze and the filtrate was centrifuged at 30 x g
for 10 minutes. The supernatant was discarded and the pellet
was resuspended in 20 to 30 ml of Dulbecco's Modified Eagle
Medium (DMEM) with 10% fetal bovine serum (FBS), 1%
glutamine, 1% streptomycin, 1% penicillin. The mixture was
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placed in a 75 cm2 polystyrene tissue culture flask (Corning) and
maintained at 37°C with 95% air/5% CO2. After 24 hours of
incubation, the media was gently replaced to remove tissue
debris and non-adherent cells. After 7 to 10 days the confluent
cells underwent first passage. All experiments were conducted
on third and fourth passage cells.
Cell characterization
The cultured renal cortical cells were characterized with
monoclonal immunostaining. Minimal or no staining was seen
for desmin or factor VIII-vWF. All cells showed moderate
staining for actin. Bright fluorescence, consistent with interme-
diate filaments, was seen for all cells using the anti-cytokeratin
monoclonal antibody. This monoclonal antibody staining pat-
tern is consistent with a homogeneous primary culture of cells
of epithelial origin [11, 12].
The hormonal stimulation of cAMP was used to further
delineate the origin of these epithelial cells. Confluent RCEC
cultures from two subjects were incubated with i0— M para-
thyroid hormone (PTH), 10—6 M calcitonin and 106 M arginine
vasopressin (AVP) for 15 minutes. Supernatants were then
replaced with a solution containing 150 msi KCI, 5 m potas-
sium phosphate, 2 mrt EDTA and 0.5 mr'i 3-isobutyl-1-meth-
ylxanthine (pH 6.8), and the cells were scraped into this
medium and the suspension was then immediately sonicated
and boiled for five minutes Samples from both the plate
supernatants and cell fraction were stored frozen for measure-
ment of cAMP after acetylation by a standard radioimmunoas-
say performed by the University of Michigan Diabetes Re-
search and Training Center. Stimulation with AVP failed to
increase in cAMP. In the first subject, stimulation of RCEC
with PTH and calcitonin resulted in a 3.7- and 1.4-fold increase
in cell fraction and 3.7- and 2.2-fold increase in supernatant
cAMP over controls, respectively. In the second subject calci-
tonin stimulation increased cell fraction and supernatant cAMP
1.3- and 3.4-fold over control, respectively. These results are
compatible with hormone sensitive, renal epithelial cells of
tubule origin [10, 131.
Northern blot analysis
Total cellular RNA from the stimulated renal cortical cells was
isolated using a modification of the method of Chirgwin et al [141
and Jonas, Sargent and Davis [15]. Total RNA was separated by
Northern blot analysis using formaldehyde in 1% agarose gels,
transblotted to nitrocellulose, baked, prehybridized, and then
hybridized with a 32P 5' end-labeled oligonucleotide DNA probe.
A thirty-mer oligonucleotide probe complementary for human
IL-8 (5'- GTT -GGC-OCA -GTG -TGG -TCC-ACT-CTC-AAT-
CAC-3') was used under conditions we have previously defined
as specific for IL-8 [6, 7]. Autoradiograms were quantified using
laser densitometry (Ultrascan XS, LXB Instruments, Inc.,
Houston, Texas, USA). Equivalent loading of total RNA per
lane was assessed by ethidium bromide stained 28S and 18S
rRNA.
Inter/eukin-8 ELISA
IL-8 antigen was quantitated using a modified, double ligand
ELISA method, as previously described [16, 171. Briefly,
flat-bottomed 96-well microtiter plates (Nunc Immuno-Piate I
96-F) were coated with rabbit anti-IL-8 antibody (9.5 g in 100
p1, 0.1 M NaHCO3, pH 9.6) for 16 hours at 4°C and then washed
with phosphate buffered saline, pH 7.5/0.5% Tween-20 (wash-
ing buffer). Nonspecific binding sites were blocked with 2%
bovine serum albumin in washing buffer and incubated for one
hour at 37°C. Plates were rinsed three times with washing buffer
and diluted samples (100 /Ll) in duplicate were followed by
incubation for 120 minutes at 37°C. Plates were washed three
times, biotinylated rabbit anti-IL-8 (final concentration 1:2000)
was added, and plates were incubated for 90 minutes at 37°C.
Plates were washed three times, then streptavidin-peroxidase
conjugate (Dakopatts, Denmark) was added and incubated for
30 minutes at 37°C. Plates were washed three times and citrate
phosphate-buffered orthophenylenediamine solution (Dako-
patts) was added and incubated for approximately five minutes
at room temperature to the desired extinction. The reaction was
then terminated with 3 M H2S04. Plates were read at 490 nm in
an ELISA reader. Standards were 1/2 log dilutions of recombi-
nant human IL-8, from 1000 ng to 0.05 pg per well. This ELISA
method consistently detected IL-8 concentrations above 50
pg/mi.
Immunohistochemistry
Immunolocalization of IL-8 antigen was performed by fixing
renal cortical cells grown on 8 chamber LabTek (Nunc, Inc.,
Naperville, Illinois, USA) slides in 4% paraformaldehyde in
PBS for 10 minutes, then rinsing twice with PBS. Prior to
staining, the slides were again fixed for 15 minutes in 1:1
absolute methanol and 3% H2O2, rinsed in PBS, and nonspecific
binding sites blocked with a 1:50 dilution of normal goat serum.
Normal serum was removed, followed by the addition of either
normal rabbit serum (1:2000 dilution) or rabbit antihuman IL-8
serum (1:2000 dilution). After 15 minutes of incubation at 37°C,
the slides were rinsed with PBS, overlaid with biotinylated goat
antirabbit IgG (1:200; Vector Laboratories), incubated 15 min-
utes, and rinsed two times with PBS. The slides were treated
with Streptavidin conjugated to peroxidase for 15 minutes at
37°C, rinsed three times, over laid with substrate chromogen
(3-amino 9-ethylcarbazoie) for seven minutes at 37°C to allow
color development, and rinsed with distilled water. Mayer's
hematoxylin was used as counterstain. Processing of human
renal allograft material was performed as follows. Formalin
fixed, paraffin embedded sections were cut from a needle core
biopsy of a human renal allograft and placed on polylysine-
coated plastic slides. The sections were deparaffinized with
xyiene wash x 2, rehydrated using stepwise increasing water/
ethanol concentrations, and then placed in PBS. Thereafter
immunohistochemical staining for IL-8 was done as described
above, except for the substitution of an avidin bound phos-
phatase-chromogen system (Vector). Antibody specificity was
demonstrated by competitive inhibition studies, in which
recombinant IL-8 when preincubated with the anti-IL-8 anti-
body, resulted in complete inhibition of immunostaining. In
addition, IL-8 affinity purified anti-IL-8 showed similar results
to that of non-affinity purified anti-IL-8 antibody.
Reagents
Reagents used in this study were: DMEM (Whittaker, Walk-
ersville, Maryland, USA), trypsin, glutamine, penicillin, strep-
tomycin (Hazleton, Lenexa, Kansas, USA), fetal bovine serum
(FBS; Biocell, Carson, California, USA). LPS (E. co/i 0111:
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B4), PTH, and AVP (Sigma Chemical Co., St. Louis, Missouri,
USA). Human recombinant IL-l/3 with a specific activity of 30
U/ng was from the Upjohn Co. (Kalamazoo, Michigan, USA).
Human recombinant TNF with specific activity of 22 U/ng was
supplied by Genetech (South San Franciso, California, USA).
Human recombinant IL-8 was purchased from Peprotech
(Rocky Hill, New Jersey, USA). IL-8 antiserum was produced
by immunization of rabbits with recombinant human IL-8 in
multiple intradermal sites with complete Freund's adjuvant
(Sigma) [18]. IL-8 antiserum, in concentrations used in the
ELISA or immunohistochemical localization of antigenic IL-8,
reacted with human recombinant IL-8 in Western analysis, and
failed to cross react with CTAP-III, NAP-2, beta-thrombogiob-
ulin, GRO/MGSA or platelet factor 4. Monoclonal antibodies
were: aDesmin (Labsystems, Helsinki, Finland), aCytokeratin
and aActin (Enzo Diagnostics, Inc., New York, New York,
USA), aVWF-factor VIII (Miles, Inc., Kankakee, Illinois,
USA), aVimentin (Boehringer Mannheim Biochemicals, India-
napolis, Indiana, USA).
Statistical analysis
The individual experiments described were performed in
tissue obtained from six human subjects. To accommodate for
variability in the absolute response from each subject, the
results were expressed as a percent of the maximal response for
each subject. Data were analyzed using the Staview II statisti-
cal software package (Abacus Concepts, Inc.) run on a MacIn-
tosh II computer (Apple, Inc., Cupertino, California, USA).
Data are expressed as means SEM. ANOVA with the Scheffe
test was used to detect significant differences between the group
means.
Human subjects
Human renal tissue was obtained using methods approved by
the University of Michigan Hospitals Human Use Committee.
Results
IL-8 gene expression: Dose dependant analysis of steady
state IL-8 mRNA
Initial studies were performed to determine whether human
RCEC expressed IL-8 mRNA in the presence of either IL-l3,
TNF or LPS. These cells were stimulated with IL-l/3 (0.02 to 20
nglml), TNF (0.02 to 20 ng/ml) or LPS (0.1 to 10 gIml) for eight
hours and then total RNA was isolated (N = 6). Control cells
were maintained and processed in the same manner but were
not stimulated. The Northern blot analysis of the dose-depen-
dent expression of RCEC-derived IL-8 mRNA is shown in
Figure 1. A Northern blot from a representative subject is
shown in Figure 1A. Laser densitometry of IL-8 mRNA was
pooled from a total of six subjects and these data are shown in
Figure lB. Stimulation by IL-lp, TNF or LPS resulted in a 25-
(P < 0.01), 7- (P < 0.05), and 6- (P < 0.01) fold increase in
steady state IL-8 mRNA over unstimulated control, respec-
tively. In other experiments we have found that as little as 2
pg/mi IL-l/3 could induce IL-8 mRNA (data not shown). The
half maximal induction of steady state IL-8 mRNA was seen
with 0.2 nglml, 2.0 nglml, 10 ng/ml for IL-1/3, TNF and LPS,
respectively. Although these data indicated that all three prom-
fiammatory stimuli were effective for the induction of RCEC-
Fig. 1. Dose dependent expression of steady-state IL-8 mRNA from
human renal cortical epithelial cell cultures after proinflammatory
stimulation. A. Northern blot with corresponding laser densitometry
from a representative subject. The stimuli concentrations are in de-
creasing order. The 28S and I 8S rRNA represents equivalent loading of
total RNA. B, Mean fold increase over control of steady state IL-8
mRNA for 6 subjects. The stimuli concentrations are in increasing
order.
derived IL-8 mRNA, IL-1f3 appeared to be the most consis-
tently potent agonist. In separate experiments, we found that
either IL-1f3, TNF or LPS stimulation in the presence of 100
mM cyclohyeximide resulted in superinduction of RCEC-de-
rived IL-8 mRNA (data not shown).
IL-8 gene expression: Time dependent analysis of steady
state IL-S mRNA
To define the temporal expression of IL-8 mRNA after
proinflammatory agonist stimulation, the following experiments
were performed. RCEC were stimulated with IL-1/3 (0.2 nglml),
TNF (2 ng/ml) and LPS (1 sg/ml) for the specified periods of
time and total RNA was isolated (N = 6). Control cells were not
stimulated but were similarly maintained and processed as
stimulated cells. The kinetic analysis of steady state levels of
1
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ulation. To determine whether IL-8 mRNA was translated into
IL-8 peptide, immunocytochemical localization of IL-8 antigen
from RCEC was performed using an avidin bound peroxidase
(brown pigment). RCEC were stimulated with either IL-1/3 (2
nglml), TNF (20 ng/ml) or LPS (1 pgIml) for 24 hours, then fixed
and immunostained for cell associated IL-8 antigen. As shown
in Figure 3, greater than 95% of the RCEC stimulated by either
IL-l/3, TNF or LPS demonstrated a cytoplasmic distribution of
antigenic IL-8 as compared to the negative serum control.
Staining for IL-8 antigenic peptide was seen as early as four
hours post-stimulation (data not shown).
Extracellular IL-8 antigen
Having shown that IL-8 mRNA was expressed in both a time-
and dose-dependent fashion, as well as being translated into
cell-associated antigenic peptide after proinflammatory agonist
stimulation, we next determined whether either IL-l/3, TNF or
LPS stimulation resulted in secreted IL-8 antigen. RCEC from
six subjects were either stimulated in a concentration or time
dependent manner with IL-1f3, TNF or LPS. RCEC superna-
tants were isolated and then assayed for antigenic IL-8 by
ELISA. The eight hour control level of supernatant IL-8 in
these experiments was 10.9 4.9 ng/ml. In Figure 4A, secreted
antigenic IL-8 is seen to increase in response to increasing
concentrations of proinflammatory agonist stimulation. Maxi-
mal secretion of IL-8 occurred at approximately 2 nglml IL-l/3
(P < 0.001), 20 nglml TNF and 1 pg/ml LPS (P <0.001).
Half-maximal stimulation was seen at 0.2 ng/ml, 2 ng/ml and 100
ng/ml with IL-113, TNF and LPS, respectively. As shown in
Figure 4B, supernatant IL-8 was detected at approximately two
to four hours, four to eight hours, and four to eight hours for
IL-113, TNF and LPS, respectively. For each of the three
proinflammatory agonists, maximal supernatant IL-8 occurred
24 hours post-stimulation.
Fig. 2. Time dependent expression of steady-state IL-S mRNA from
human renal cortical epithelial cell cultures after proinflam,nato,y
stimulation. A. Northern blot with corresponding laser densitometry
from a representative subject. The 28S and 18S rRNA represents
equivalent loading of total RNA. B. Mean fold increase over control of
steady state IL-8 mRNA for 6 subjects.
RCEC-derived IL-8 mRNA is shown in Figure 2. A repre-
sentative Northern blot is shown in Figure 2A and a summary of
Northern blots from RCEC-derived IL-8 mRNA from six
subjects is shown in Figure 2B. In Figure 2A, IL-13 is shown to
stimulate the most rapid and greatest expression of IL-8
mRNA. The averaged data from these experiments (Fig. 2B)
demonstrate increasing expression of IL-8 mRNA with time
after stimulation by IL-1/3, TNF and LPS, with maximal
expression seen at 24 hours for these agonists. IL-1j3 resulted in
maximal IL-8 steady-state mRNA expression.
Cell associated JL-8 antigen
The results of experiments discussed thus far indicate that
RCEC have the capacity to express IL-8 mRNA in both a dose..
and time-dependent manner after proinflammatory agonist stim-
Cell associated IL-S in acutely rejecting human renal
alto graft
Since our in vitro studies of human renal cortical epithelial
cells demonstrated expression, translation and secretion of IL-8
after stimulation with IL-l/3, TNF and LPS, we next deter-
mined whether IL-8 had exaggerated expression under condi-
tions of acute human renal allograft rejection. Renal tissue was
obtained from an allograft biopsy at day 9 post-transplant from
three patients with pathologic diagnosis of acute allograft rejec-
tion. Figure 5 shows the immunohistochemical localization of
IL-8 antigen using an avidin bound phosphatase (pink pigment)
from a representative biopsy specimen. Control sera failed to
show non-specific immunostaining (Fig. 5A), however, anti-
IL-8 immune sera demonstrated cell associated IL-8 localized
to the cytoplasm of both proximal and distal renal tubular cells
(Fig. SB). Normal human renal tissue failed to immunostain for
IL-8 (data not shown).
Discussion
In this study we present evidence that human renal cortical
epithelial cells, of tubule origin, can express and secrete IL-8, a
potent neutrophil and lymphocyte chemotactic peptide. These
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Fig. 3. immunoperoxidase localization of IL-8 from human renal cortical epithelial cells after 24 hr incubation with the following stimuli. A. 20
ng/ml TNF; B. 2.0 nglml IL-1/3; C. 1.0 g/ml LPS; D. the 24 hour control with preimmune serum.
secondary (IL-1f3 or TNF) stimulus in both a time- and dose-
dependent fashion by the expression of IL-8 mRNA and the
production of IL-8 antigen. In addition, both distal and proxi-
mal renal tubular epithelial cells from a rejecting human renal
allograft were shown to manifest cell-associated antigenic IL-8
peptide. Thus, in the human kidney, recruited inflammatory
cells may receive chemotactic information from several
sources, including resident interstitial mononuclear phago-
cytes, newly recruited mononuclear cells and renal tubular
epithelial cells. The contribution of the renal tubule epithelial
cell in directing inflammatory cell traffic may have particular
importance in renal allograft rejection, where the recruitment of
leukocytes could be dependent upon activation of allograft
tubular epithelial cells. However, other types of tubulointersti-
tial disease including pyelonephritis, vasculitis and allergic
interstitial nephritis could also be mediated, in part, by similar
mechanisms. This is one of the first reports of primary epithelial
cell cultures from a human organ expressing and secreting IL-8.
Recently, IL-8 mRNA expression and protein production has
been reported in human retinal pigment epithelia [19].
Both primary (exogenous) and secondary (endogenous) types
of proinflammatory agonists mediate RCEC expression and
secretion of IL-8. In contrast to other epithelia, LPS can serve
as a primary stimulus for the expression and secretion of IL-8
by RCEC, similar to mononuclear phagocytes [3] and endothe-
ha! cells [71. LPS-induced IL-8 production may be important in
the setting of acute pyelonephritis, in which the predominant
etiologic agent, the gram negative bacterium, is a principle
source of LPS. By responding to LPS, renal tubular cells could
rapidly induce a host inflammatory response with the genera-
tion of IL-8 without need for intermediate immune cell-derived
cytokines.
The cytokines IL-I f3 and TNF are early response, inflamma-
tory cytokines of the immune system. IL-lf3 is secreted by a
variety of cell types including mononuclear phagocytes, mesan-
gial cells, endothehial cells and fibroblasts [20—221. Stimuli for
the induction of IL-I from these cells includes LPS, C5a,
immune complexes interferon-y, and IL-2 [20, 23, 24]; TNF
producing cells are principally mononuclear phagocytes and
T-lymphocytes [25, 26]. A variety of stimuli are important for
the induction of TNF, depending upon the cell type studied [27,
281. Both of these polypeptides have pleiotropic effects in a
number of cell systems [27]. In a positive feedback fashion,
IL-1f3 can stimulate the expression of its own receptor, thus,
functioning at a local level to amplify the inflammatory response
[29]. The capacity of renal tubular epithelial cells to respond to
IL-l/3 is evident from several recent reports. IL-i can modulate












Fig. 4. The dose (A) and time (B) dependent
production of antigenic IL-8 from human
renal cortical epithelial cell cultures after
proinflammatory stimulation. IL-8 productionJ expressed as the mean fold increase over
control (N = 6).
tubular epithelium [30], as well as induce naturesis in rats
through probable tubular mechanisms [31]. We have shown that
IL-lp and TNF can stimulate renal tubular cells to express IL-8
mRNA and secrete antigenic IL-8. By responding to IL-1/3 and
TNF, the renal tubule epithelial cell is not only capable of
altering its tubular functions but also able to participate with
both monocytes and lymphocytes in a cytokine coordinated
network to recruit inflammatory leukocytes.
In the setting of acute rejection of a renal allograft, we have
shown immunohistochemical staining for IL-8 in human renal
tubular cells. The intense nature of this staining, coupled with
the large mass of tubular cells in the kidney, is evidence of the
potential of human renal allograft epithelium to participate in
acute rejection by establishing an IL-8 chemotactic gradient for
leukocytes. In the non-infected renal allograft, the induction of
IL-8 in tubular cells is presumably through the production of
signals from either host lymphocytes or mononuclear phago-
cytes that are activated by foreign MHC antigens. These
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Fig. 5. Immunohistochemical localization of
antigenic IL-8 from a representative biopsy
specimen from an acutely rejecting human
renal allograft. A. Control with preimmune
serum. B. IL-8 immune serum.
inflammatory signals likely include IL- 113 and TNF, both of
which have been implicated as important immune stimuli in
acute allograft rejection [32, 331.
These studies further support the role of the human renal
tubular epithelial cells as effector cells that are important
participants in the initiation and maintenance of renal inflam-
matory responses.
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